J. Dorin et al.; Cystic fibrosis in the mouse by targeted insertional mutagenesis Nature 359:211-215 (1992). |
J. L. Breslow; Transgenic mouse models of lipoprotein metabolism and atherosclerosis Proc. Natl. Acad. Sci. U.S.A. 90:8314-8318 (1993). |
Dutch-Belgian Fragile X Consortium; Fmr1 Knockout Mice: A Model to Study Fragile X Mental Retardation Cell. 78:23-33 (1994). |
V. L. J. Tybulewicz et al.; Neonatal Lethality and Lymphopenia in Mice with a Homozygous Disruption of the c-abl Proto-Oncogene Cell. 65:1153-1163 (1991). |
E. Lee et al., Mice deficient for Rb are nonviable and show defects in neurogensis and haematopoiesis Nature 359:288-294 (1992). |
G. L. Merlino; Transgenic animals in biomedical research FASEB J. 5:2996-3001 (1991). |
M. Barinaga; Knockout Mice Offer First Animal Model for CF Science 257:1046-1047 (1992). |
J. M. Rommens et al.; "A Transcription Map of the Region Containing the Huntington Disease Gene", Human Molecular Genetics; 2 No. 7:901-907 (1993). |
A. B. Sachs, "Messenger RNA Degradation in Eukaryotes", Cell; 74:413-421. |
H. Yasueda et al.; High-Level Direct Expression of Semi-Synthetic Human Interleukin-6 in Escherichia Coli and Production of N-Terminus Met-Free Product, Bio/Technology 8:1036-1040 (1990). |
The Huntington's Disease Collaborative Research Group, A Novel Gene Containing a Trinucleotide Repeat that is Expanded and Unstable on Huntington's Disease Chromosomes, Cell 72:971-983 (1993). |